Indian-origin expert explains failure of first inhaled insulin product
September 24th, 2009 - 4:37 pm ICT by ANIWashington, September 24 (ANI): An Indian-origin expert at the University of Colorado Denver has shed light on why an inhaled insulin product turned out to be a commercial failure.
Dr. Satish K. Garg, a professor of Medicine and Pediatrics at the University of Colorado Denver, says that the results of a 2-year Phase 3 trial conducted in 385 patients suggest that AIR inhaled insulin was inferior to SC insulin in its ability to maintain optimal blood glucose levels over time, based on measurements of glycosylated hemoglobin (HbA1c).
Similarly, another study on 500 patients with type 1 diabetes showed inferiority of AIR in a 6-month trial.
“The question now remains whether this route of delivering insulin has been exhausted or if it still remains to be explored,” writes Dr. Satish Garg, who is also the Editor-in-Chief of Diabetes Technology & Therapeutics, and William Kelly, from the University of Colorado Denver.
An editorial titled ‘Insulin Delivery via Lungs-Is It Still Possible?’ says that a company called MannKind Corporation has recently filed a New Drug Application with the Food and Drug Administration (FDA) for Technosphere Insulin.
It offers faster onset of action with lower postprandial blood glucose excursions especially in the first two hours and is weight neutral, according to the Editorial. (ANI)
- Scientists uncover gut bug link to type 2 diabetes - Mar 14, 2012
- Blood glucose levels indicator of retinopathy risk - Feb 15, 2011
- Growing use of insulin devices may improve diabetes management - Jun 09, 2010
- Structured exercise training helps lower diabetics' blood sugar - May 04, 2011
- Insulin pumps may benefit diabetics - Jan 16, 2010
- Diabetes linked to irregular heartbeat - Apr 23, 2010
- Nicotine raises blood sugar among diabetic smokers: Study - Mar 28, 2011
- 2 tests better than 1 for diagnosing diabetes in overweight children - May 03, 2011
- Intense diabetes treatment could make sugar levels go 'too low' - Jan 27, 2010
- Diabetics' conditions improved after phone calls with fellow patients - Oct 19, 2010
- Exenatide - a physiological option for a pathological disease. - Sep 17, 2009
- Obstructive sleep apnea 'can make diabetes worse' - Jan 15, 2010
- Hemoglobin A1c test better indicator of diabetes risk - Mar 04, 2010
- Combining aerobic and resistance training helpful for diabetics - Nov 24, 2010
- Self-monitoring of blood glucose highly effective in diabetes care - May 30, 2008
Tags: blood glucose levels, commercial failure, diabetes technology, drug application, food and drug administration, food and drug administration fda, hemoglobin, indian origin, inferiority, inhaled insulin, insulin delivery, insulin product, origin expert, patients with type, postprandial, satish garg, type 1 diabetes, university of colorado, university of colorado denver, william kelly
